| Market Cap | 799M 712M 664M 604M 1.14B 76.93B 1.15B 8.01B 3.12B 39.23B 3B 2.93B 126B | P/E 2023 |
2,007x | P/E 2024 | -3.42x |
|---|---|---|---|---|---|
| Enterprise Value | 964M 859M 801M 729M 1.37B 92.86B 1.38B 9.67B 3.76B 47.35B 3.62B 3.54B 152B | EV / Sales 2023 |
8.58x | EV / Sales 2024 | 4.64x |
| Free-Float |
98.58% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -2.83% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 15/09/2025 | |
Richard McAvoy
DFI | Director of Finance/CFO | - | 01/06/2026 |
David Stewart
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.83% | +7.69% | - | - | 799M | |
| +0.02% | -3.41% | +36.11% | +115.09% | 1,019B | |
| -1.21% | -6.74% | +34.08% | +62.64% | 617B | |
| +1.12% | +0.54% | +13.62% | +79.94% | 464B | |
| -3.30% | -6.21% | +56.45% | +36.58% | 356B | |
| +0.93% | -3.16% | +21.65% | +43.02% | 333B | |
| +0.12% | -2.77% | +10.70% | +32.97% | 267B | |
| -0.89% | -6.28% | -7.00% | +8.01% | 244B | |
| -0.01% | -2.81% | +35.28% | +51.82% | 218B | |
| -0.08% | -4.17% | +28.34% | +93.51% | 179B | |
| Average | -0.46% | -3.54% | +25.47% | +58.17% | 410.8B | |
| Weighted average by Cap. | -0.06% | -3.54% | +28.50% | +70.11% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 149M 133M 124M 113M 213M 14.37B 214M 1.5B 582M 7.33B 560M 548M 23.57B | 140M 125M 116M 106M 199M 13.47B 201M 1.4B 546M 6.87B 525M 514M 22.09B |
| Net income | 560K 499K 465K 424K 798K 53.93M 804K 5.62M 2.19M 27.5M 2.1M 2.06M 88.42M | -141M -125M -117M -106M -201M -13.55B -202M -1.41B -549M -6.91B -528M -517M -22.22B |
| Net Debt | 151M 135M 126M 114M 216M 14.56B 217M 1.52B 590M 7.43B 568M 555M 23.88B | 165M 147M 137M 125M 236M 15.92B 237M 1.66B 645M 8.12B 621M 607M 26.1B |
Employees
-
Sector
Pharmaceuticals
